Dialysis: The Story So Far
Dialysis holds a special place in U.S. medicine. In the 1960’s, it was the nation’s signature example of rationing, an expensive miracle therapy available only to a lucky few. A decade later, when Congress created a special entitlement to pay for it, dialysis became the country’s most ambitious experiment in universal care.
Today, dialysis is a lifeline for almost 400,000 Americans. Yet, despite massive expense by U.S. taxpayers, Americans endure some of the worst outcomes for dialysis care in the industrialized world. One in five patients dies each year. Those that survive often grapple with frequent hospitalizations and poor quality of life.
An investigation by ProPublica found that patients often received treatment in environments that were unsafe or unsanitary. A review of inspections conducted between 2002 and 2009 at more than 1,500 clinics turned up hundreds of instances in which facilities were cited for breaches in infection control, as well as egregious cases in which lapses in care may have led to patient injuries or deaths. Though clinics are supposed to be checked once every three years on average, we found that hundreds had not been inspected for five years or more. Moreover, we found, the government was withholding critical data about clinics' performance from the public.
ProPublica obtained this data under the Freedom of Information Act and, in December, posted it in searchable form. Officials with the Centers for Medicare and Medicaid Services (CMS) are now providing this information to anyone upon request and say they are working to add it to Medicare’s Dialysis Compare web site. In response to Sen. Charles Grassley, R-Iowa, who has pressed CMS to spell out what steps it was taking to improve dialysis care, the agency said it was working on an initiative to reduce infections in dialysis clinics and would be releasing a comprehensive action plan later this year.
Dialysis: High Costs and Hidden Perils of a Treatment Guaranteed to All
Nearly 40 years after Congress created a unique entitlement for patients with kidney failure, U.S. death rates and per-patient costs are among the world's highest while the biggest for-profit providers flourish.
The Story So Far
Dialysis holds a special place in U.S. medicine. In the 1960’s, it was the nation’s signature example of rationing, an expensive miracle therapy available only to a lucky few. A decade later, when Congress created a special entitlement to pay for it, dialysis became the country’s most ambitious experiment in universal care.
Safeguard the public interest.
Billions in tax dollars keep 400,000 Americans on dialysis alive, but the system is riddled with problems. Help us keep this important investigation going.
Latest Stories in this Project
Get Updates
Our Hottest Stories
- The 182 Percent Loan: How Installment Lenders Put Borrowers in a World of Hurt
- IRS Office That Targeted Tea Party Also Disclosed Confidential Docs From Conservative Groups
- Medicare Drug Program Fails to Monitor Prescribers, Putting Seniors and Disabled at Risk
- On Victory Drive, Soldiers Defeated by Debt
- The Most Important #Muckreads on Rape in the Military
- Everything We Know About What’s Happened Under Sequestration
- The Story Behind Our Hospital Interactive
- Is Obama Delivering on His Promise of a “21st Century” Approach to Drugs?
- Lifting the Veil on Dangerous Prescribing
- FAQ: What You Need to Know About Prescriber Checkup
- IRS Office That Targeted Tea Party Also Disclosed Confidential Docs From Conservative Groups
- The 182 Percent Loan: How Installment Lenders Put Borrowers in a World of Hurt
- Everything We Know About What’s Happened Under Sequestration
- On Victory Drive, Soldiers Defeated by Debt
- Medicare Drug Program Fails to Monitor Prescribers, Putting Seniors and Disabled at Risk
- How the IRS’s Nonprofit Division Got So Dysfunctional
- Is Obama Delivering on His Promise of a “21st Century” Approach to Drugs?
- Intern vs. Mayor: Battle Bares Bloomberg's Argument for Secrecy
- The Most Important #Muckreads on Rape in the Military
- How We Analyzed Medicare’s Drug Data






